about
The FTLD risk factor TMEM106B and MAP6 control dendritic trafficking of lysosomesEarly mechanisms of pathobiology are revealed by transcriptional temporal dynamics in hippocampal CA1 neurons of prion infected miceCognitive decline in normal aging and its prevention: a review on non-pharmacological lifestyle strategies.Studying synapses in human brain with array tomography and electron microscopyREGION-SPECIFIC NEURON AND SYNAPSE LOSS IN THE HIPPOCAMPUS OF APPSL/PS1 KNOCK-IN MICENovel pathophysiological markers are revealed by iTRAQ-based quantitative clinical proteomics approach in vascular dementia.The effects of two polymorphisms on p21cip1 function and their association with Alzheimer's disease in a population of European descentValosin-containing protein and neurofibromin interact to regulate dendritic spine densityAcupuncture attenuates cognitive deficits and increases pyramidal neuron number in hippocampal CA1 area of vascular dementia ratsDiet-induced obesity attenuates cytokine production following an immune challenge.Aerobic exercise regulates Rho/cofilin pathways to rescue synaptic loss in aged ratsA combination extract of ginseng, epimedium, polygala, and tuber curcumae increases synaptophysin expression in APPV717I transgenic miceExpression of Glutamate and GABA during the Process of Rat Retinal Synaptic Plasticity Induced by Acute High Intraocular Pressure.Curcumin/melatonin hybrid 5-(4-hydroxy-phenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide ameliorates AD-like pathology in the APP/PS1 mouse model.β amyloid peptide plaques fail to alter evoked neuronal calcium signals in APP/PS1 Alzheimer's disease miceA high-throughput framework to detect synapses in electron microscopy images.Caprospinol: discovery of a steroid drug candidate to treat Alzheimer's disease based on 22R-hydroxycholesterol structure and properties.Building a Terminal: Mechanisms of Presynaptic Development in the CNS.Synaptic activity protects against AD and FTD-like pathology via autophagic-lysosomal degradation.Synaptic changes in frontotemporal lobar degeneration: correlation with MAPT haplotype and APOE genotype.White matter damage and glymphatic dysfunction in a model of vascular dementia in rats with no prior vascular pathologies.Protective effects of Dendrobium nobile Lindl. alkaloids on amyloid beta (25-35)-induced neuronal injury.Spatiotemporal alterations of presynaptic elements in the retina after high intraocular pressure.Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease.Aerobic exercise combined with antioxidative treatment does not counteract moderate- or mid-stage Alzheimer-like pathophysiology of APP/PS1 mice.Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease.Neuroprotective effects of bajijiasu against cognitive impairment induced by amyloid-β in APP/PS1 mice.Plasminogen activator inhibitor-1 promotes synaptogenesis and protects against aβ(1-42)-induced neurotoxicity in primary cultured hippocampal neurons.Reduced Synapse and Axon Numbers in the Prefrontal Cortex of Rats Subjected to a Chronic Stress Model for Depression.Chinese Herbal Medicine Xueshuantong Enhances Cerebral Blood Flow and Improves Neural Functions in Alzheimer's Disease Mice.Distinguishing normal brain aging from the development of Alzheimer's disease: inflammation, insulin signaling and cognitionCerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementiasCell cycle reentry triggers hyperploidization and synaptic dysfunction followed by delayed cell death in differentiated cortical neurons
P2860
Q24314869-F72ACADB-BB32-4A6C-99FD-0D8F82A605E6Q27340506-2F903B65-A427-4CAD-B47C-F18E393E4617Q30402721-25913A3E-E93C-4FF8-A404-2B258531E424Q30541526-EA95A73C-A875-44E8-B02D-1E138E1CC13CQ33598997-B94D64A8-93A4-44BC-BE97-C22E6CC8F560Q33624463-D37EABD3-EED0-4684-BB65-A9399368B190Q35549840-55730083-036F-4B06-908A-C12067D4AAF2Q35578562-FB4C6F3E-2C35-471B-951A-E34FFD89274CQ35589311-DBC79575-8E06-4931-A5F4-FE29493B4E7AQ35762513-BA5FD540-1C9F-4B42-818F-630A23A4EF5AQ36267857-D5E337C9-7C08-4CB5-9E26-42D6C3ACAEAAQ36430458-E72B02DB-7116-4169-86BC-5B34869FEC90Q36681608-236C6339-1EF9-41B0-B5C6-C2BE1FAC4404Q36794953-B0F3EEAB-4854-41A4-BBE5-49825D61F417Q36877633-29A66C2E-88F6-4E9A-ABB7-483A38BDF5A2Q36960689-B8F874CE-CB78-4E59-85E2-692BE2F9B826Q37882023-DDF25F55-A153-439C-ACE8-B4E41C231BF2Q38553730-9AF5DAB7-1807-4149-B408-E6B854976728Q38684346-7E421FB1-6ED8-4C67-8C2E-B19D3BA22E0DQ39817807-A4DC71B4-A74F-4A0C-BBB7-0A2E71ED2F2AQ40430696-338EF14A-AEA2-4109-8600-DB6FF7620FB0Q41429884-AC692106-9A9F-4891-9F55-B2EF33B2AB84Q42104651-50AC467D-F8FE-492E-9CBD-5CFF13DD4CE5Q44909742-3F20A872-5A10-426F-838B-BCB93E10C081Q45323391-20EAB56F-10A8-4F50-813D-3D6ABF61120FQ46276104-C017FC0D-BD68-4044-A9A5-18F3FD9A623DQ47098610-9E754EFD-4C94-43FA-A5E8-CB9E7784EFA0Q48392806-E3345A85-6912-454F-932A-FD59F23A97D7Q49235221-C06E392F-3E60-43F5-A8A2-E156339F62B8Q55259822-349C4A9D-D704-44E0-B546-ED36EBBEBC76Q57143976-D5C77EA7-1970-4082-B878-FE455A03B26DQ57750814-9740663B-89CB-4F74-908C-DD83DDA76110Q58698855-1AE1E30D-C9A8-40D8-89FB-60975B03795A
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Synapse loss in dementias.
@ast
Synapse loss in dementias.
@en
Synapse loss in dementias.
@nl
type
label
Synapse loss in dementias.
@ast
Synapse loss in dementias.
@en
Synapse loss in dementias.
@nl
prefLabel
Synapse loss in dementias.
@ast
Synapse loss in dementias.
@en
Synapse loss in dementias.
@nl
P2093
P2860
P356
P1476
Synapse loss in dementias.
@en
P2093
Martin Wirenfeldt
Ryan Clare
Victoria G King
P2860
P304
P356
10.1002/JNR.22392
P577
2010-08-01T00:00:00Z